Literature DB >> 30312657

In Cochrane reviews, risk of bias assessments for allocation concealment were frequently not in line with Cochrane's Handbook guidance.

Ivana Propadalo1, Mia Tranfic1, Ivana Vuka1, Ognjen Barcot2, Tina Poklepovic Pericic3, Livia Puljak4.   

Abstract

OBJECTIVES: The aim of the article was to analyze whether the risk of bias (RoB) judgments for allocation concealment in Cochrane systematic reviews (CSRs) were in line with recommendations from the Cochrane Handbook. STUDY DESIGN AND
SETTING: From CSR, we extracted data about judgments and supporting comments about allocation concealment for each included randomized controlled trial (RCT). We compared whether judgments for supporting comments were in line with Cochrane Handbook recommendations.
RESULTS: We analyzed judgments and comments of 721 CSRs in which 10,280 RCTs were included. By following the Cochrane Handbook guidance, we found that judgments for allocation concealment were discrepant for 2,928 trials (29%). Most discrepancies were made for trials where RoB was judged as low (2,693 trials; 92%). Cochrane authors used 66 categories of comments describing envelopes as a method of allocation concealment. In 66 envelope-related categories, describing RoB assessments from 1,529 (15%) of the analyzed RCTs, most of the judgments were low RoB, although only one of those categories is associated with low RoB according to the Cochrane Handbook. Twenty categories of supporting comments, including 642 trials, were related to randomization, not allocation concealment.
CONCLUSION: One-third of RoB judgments about allocation concealment in Cochrane reviews were discrepant from the Cochrane Handbook recommendations.
Copyright © 2018 Elsevier Inc. All rights reserved.

Keywords:  Allocation concealment; Bias; Cochrane; Quality; Risk of bias; Standards; Systematic reviews

Mesh:

Year:  2018        PMID: 30312657     DOI: 10.1016/j.jclinepi.2018.10.002

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  16 in total

Review 1.  Comparing the efficacy of catheter ablation strategies for persistent atrial fibrillation: a Bayesian analysis of randomized controlled trials.

Authors:  Sijia Wu; Hongkai Li; Shaolei Yi; Jianming Yao; Xueming Chen
Journal:  J Interv Card Electrophysiol       Date:  2022-07-04       Impact factor: 1.900

2.  Second-generation cryoballoon vs. contact-force sensing radiofrequency catheter ablation in atrial fibrillation: a meta-analysis of randomized controlled trials.

Authors:  Yang Wang; Wei Wang; Jianming Yao; Lianghua Chen; Shaolei Yi
Journal:  J Interv Card Electrophysiol       Date:  2020-10-11       Impact factor: 1.900

3.  Risk of Bias and Quality of Reporting in Colon and Rectal Cancer Systematic Reviews Cited by National Comprehensive Cancer Network Guidelines.

Authors:  C Wayant; L Puljak; M Bibens; M Vassar
Journal:  J Gen Intern Med       Date:  2020-01-16       Impact factor: 5.128

4.  Quality of evidence in a post-Soviet country: evaluation of methodological quality of controlled clinical trials published in national journals from Uzbekistan.

Authors:  Timur Aripov; Dilfuza Aniyozova; Irina Gorbunova
Journal:  BMC Med Res Methodol       Date:  2020-07-13       Impact factor: 4.615

5.  Methodological tools and sensitivity analysis for assessing quality or risk of bias used in systematic reviews published in the high-impact anesthesiology journals.

Authors:  Marija Franka Marušić; Mahir Fidahić; Cristina Mihaela Cepeha; Loredana Gabriela Farcaș; Alexandra Tseke; Livia Puljak
Journal:  BMC Med Res Methodol       Date:  2020-05-18       Impact factor: 4.615

6.  Assessments of attrition bias in Cochrane systematic reviews are highly inconsistent and thus hindering trial comparability.

Authors:  Andrija Babic; Ruzica Tokalic; João Amílcar Silva Cunha; Ivana Novak; Jelena Suto; Marin Vidak; Ivana Miosic; Ivana Vuka; Tina Poklepovic Pericic; Livia Puljak
Journal:  BMC Med Res Methodol       Date:  2019-04-05       Impact factor: 4.615

7.  Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross-sectional design.

Authors:  Lorenzo Bertizzolo; Patrick Bossuyt; Ignacio Atal; Philippe Ravaud; Agnes Dechartres
Journal:  BMJ Open       Date:  2019-04-01       Impact factor: 2.692

8.  The judgement of biases included in the category "other bias" in Cochrane systematic reviews of interventions: a systematic survey.

Authors:  Andrija Babic; Andela Pijuk; Lucie Brázdilová; Yuliyana Georgieva; Marco António Raposo Pereira; Tina Poklepovic Pericic; Livia Puljak
Journal:  BMC Med Res Methodol       Date:  2019-04-11       Impact factor: 4.615

9.  Efficacy and safety of modified-release paracetamol for acute and chronic pain: a systematic review protocol.

Authors:  Zeljana Margan Koletic; Svjetlana Dosenovic; Livia Puljak
Journal:  BMJ Open       Date:  2019-10-14       Impact factor: 2.692

10.  Assessing the risk of performance and detection bias in Cochrane reviews as a joint domain is less accurate compared to two separate domains.

Authors:  Ognjen Barcot; Matija Boric; Svjetlana Dosenovic; Livia Puljak
Journal:  BMC Med Res Methodol       Date:  2021-07-18       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.